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Summary 
Itk Is a T cell protein tyroslne klnase (PTK) that, along 
with Btk and Tee, belongs to a family of cytoplasmlc 
PTKs wlth N-terminal pleckstrln homology domains. 
Btk plays a critical role In B lymphocyte development. 
To determine whether Itk has an analogous role In T 
lymphocytes, we used gene targetlng to prepare mice 
lacking expression of Itk. Such animals had decreased 
numbers of mature thymocytes, an effect most clearly 
observed in mice expressing T cell receptor (TCR) 
transgenes. Mature T cells from Itk-deficient mice had 
reduced proliferative responses to allogeneic MHC 
stlmulation and to anti-TM cross-llnking, but re- 
sponded normally to stimulation with phorbol ester 
plus ionomycin or with IL-2. These results provide ge- 
netic evidence that Itk Is involved in T cell development 
and also suggest that Itk has an Important role in proxl- 
mal events In TCR-medlated signaling pathways. 
Introduction 
Lymphocyte activation and development depend on re- 
ceptor-initiated cascades of signal transduction events in- 
volving the action of several nonreceptor protein tyrosine 
kinases (PTKs). In mature T cells, stimulation of the T cell 
antigen receptor (TCR) by antigen and major histocompat- 
ibility complex (MHC) molecules or by antibody cross- 
linking induces PTK activation, which results in tyrosine 
phosphorylation of cellular proteins and subsequent acti- 
vation of the phosphatidylinositol pathway, activation of 
Ras, and activation of several serine/threonine protein ki- 
nases and phosphatases (reviewed by Weiss and Littman, 
1994). Similar intracellular signal transduction mecha- 
nisms are also likely to be involved in differentiation of 
immature thymocytes. 
Nonreceptor PTKs involved in T cell activation and de- 
velopment include Lck and Fyn, members of the Src family 
of PTKs, and ZAP-70, which, along with Syk, forms a sepa- 
rate family of PTKs. Lck and Fyn are activated early after 
TCR cross-linking, and are thought to phosphorylate im- 
munoreceptor tyrosine-based activation motifs (ITAMs) 
within the TCR-associated CD3 and 6 polypeptides. ZAP-70 
and Syk bind to the phosphorylated ITAMs by means of 
SH2 interactions and are involved in subsequent activa- 
tion of downstream components (reviewed by Weiss and 
Littman, 1994). Mice deficient in Lck have very few periph- 
eral T cells or single-positive (SP) thymocytes and dramati- 
cally reduced numbers of doublepositive (DP) (CD4+CD8+) 
thymocytes (Molina et al., 1992). Expression of a mutant 
Ick transgene, which directs the synthesis of a dominant- 
negative form of the PTK, likewise results in early develop- 
mental arrest (Levin et al., 1993). Recent studies suggest 
that Lck is required for expansion of the DP population 
(Mombaerts et al., 1994). Mice with a targeted mutation 
in the gene encoding Fyn have a milder phenotype, with 
reduced thymocyte proliferation in response to TCR stimu- 
lation but no apparent defect in thymocyte development 
(Stein et al., 1992; Appleby et al., 1992). The discovery 
that mutations in human ZAP-70 result in a rare T cell 
immunodeficiency, which is manifested by the absence 
of mature CD8 cells and the failure of CD4 cells in the 
periphery to proliferate following TCR stimulation, indi- 
cates that ZAP-70 also has a critical role in thymocyte 
development (Arpaia et al., 1994; Chan et al., 1994; Elder 
et al., 1994). Studies of ZAP--/O-deficient mice generated 
by homologous recombination have confirmed and ex- 
tended the role of ZAP-70 in thymocyte development. 
These mice have defective positive selection, with ab- 
sence of mature CD4 and CD8 SP T cells, and defective 
negative selection, since antigen-specific ZAP-70+ thy- 
mocytes were not deleted in the presence of the peptide 
antigen (Negishi et al., 1995). 
More recently, another nonreceptor PTKof yet unknown 
function was identified in T lymphocytes. This PTK was 
named Itk (interleukin-2 (IL-2)-inducible T cell kinase) be- 
cause its expression was induced by IL-2 in IL-2-deprived 
CTLL-2 cells (Siliciano et al., 1992). The same protein has 
also been designated Tsk (Heyeck and Berg, 1993) and 
Emt (Gibson et al., 1993; Yamada et al., 1993). Itkshares 
strong amino acid homology with two other mammalian 
proteins, Bruton’s tyrosine kinase (Btk) and Tee (Vetrie et 
al., 1993; Tsukada et al., 1993; Mano et al., 1993). These 
proteins define a new family of cytoplasmic protein tyro- 
sine kinases, characterized by the presence of an N-ter- 
minal pleckstrin homology (PH) domain (Musacchio et 
al., 1993; Shaw, 1993) followed by the Src homology do- 
mains (SH3 and SH2) and a kinase domain. They lack the 
N-terminal myristylation signal and the C-terminal regula- 
tory tyrosine residue characteristic of the Src family of 
PTKs. 
Btk is preferentially expressed in cells of the B lymphoid 
and myelomonocytic lineages. Mutations in Bfkare associ- 
ated with X-linked agammaglobulinemia (XLA) in human 
(Vetrie et al., 1993; Tsukada et al., 1993) and X-linked 
immunodeficiency(xid) in mice (Thomas et al., 1993; Raw- 
lings et al., 1993). The defects in XLA and xid are both 
intrinsic to the B lineage, but the phenotypes differ signifi- 
cantly. Whereas XLA patients have few circulating mature 
B cells, xid mice, which are homozygous for a mutation 
in the Btk PH domain, have only a moderate defect in B 
cell maturation, but have defects in B cell activation and 
in the production of some immunoglobulin isotypes (re- 
viewed by Tsukadaet al., 1994). Interestingly, a null muta- 
tion in Btk results in a phenotype similar to xid (Khan et 
al., 1995). Stimulation of the antigen receptor on B cells 
and of the immunoglobulin E (IgE) receptor on mast cells 
results in tyrosine phosphotylation and increased PTK ac- 
tivityof Btk(Saouaf et al., 1994; Aoki et al., 1994; de Weers 
et al.; 1994; Kawakami et al., 1994). 
Itk is expressed preferentially in cells of the T lineage 
(Siliciano et al., 1992; Heyeck and Berg, 1993; Gibson et 
al., 1993). Its tissue distribution is restricted to thymus, 
lymph node, and spleen. In thymus, Itk mRNA has been 
detected at day 14 of fetal development, prior to the ap- 
pearance of DP thymocytes (Heyeck and Berg, 1993). Itk 
mRNA has also been detected in human natural killer (NK) 
cell lines (Gibson et at., 1993; Tanaka et al., 1993) but 
not in murine NK cells (Desiderio and Siliciano, 1994). 
Stimulation of T lymphocytes with anti-TCR or anti-CD28 
antibodies results in phosphorylation and activation of Itk 
(August et al., 1994). 
The strong homology between Btk and Itk and their ap- 
parently similar modes of activation following antigen re- 
ceptor engagement in B and T cells, respectively, have 
suggested that these PTKs have similar functions in the 
two lymphocyte lineages. To identify the functions of Itk 
and, in particular, to ask whether Itk plays an analogous 
role in T cells to that of Btk in the development of B cells, 
we generated mice with a null mutation in the itk gene. 
Mutant mice exhibited decreased numbers of mature T 
lymphocytes and, more strikingly, they had a nearly com- 
plete block in development of thymocytes bearing,defined 
transgenic TCFls. Mature T cells in mutant mice displayed 
impaired TCR-mediated proliferation. Our studies thus in- 
dicate that Itk has an important role in thymocyte matura- 
tion, most likely through its involvement downstream of 
TCR-initiated signals. 
Results 
Generation of Itk-Deficient Mice 
Several overlapping genomic clones oi the if/r gene were 
obtained from a LDASH II phage library derived from the 
129/Sv mice. Three large clones defined a contig of 20.5 
kb encompassing the putative exons 2, 3, 4, and 5. The 
putative exon 1 containing the translation initiation codon 
was not included in these genomic clones. We identified 
two splice acceptor sites preceding exon 3 (Figure 1A). 
The alternative use of the these splice sites 18 bp apart 
may explain the discrepancy of the published cDNA se- 
quences of itk (Siliciano et al., 1992; Heyeck and Berg, 
1993; Yamada et al., 1993). The organization of the 5’end 
of the itk gene is very similar to that of the mouse and 
human Bt/rgenes(Rawlings et al., 1993; Ohta et al., 1994; 
Hagemann et al., 1994; Sideraset al., 1994; Rohrer et al., 
1994). These two genes may be derived from duplication 
of a common ancestor. 
The scheme used to generate a null allele of the itkgene 
is illustrated in Figure 18. The putative exon 4 and portion 
of exon 3, as well as adjacent introns of itk were deleted 
and replaced with pgk(G)neopA. The deleted itk coding 
sequence includes a region that is highly conserved 
among the ltk/Btk/Tec family members. This region con- 
tains a tryptophan residue that is the only absolutely con- 
served amino acid among all known PH domains (Musac- 
chio et al., 1993). The poly(A) addition signal present in 
the neo cassette was expected to terminate pre-mRNAs 
from both the pgk anditk promoters, so that no Itk protein 
would be produced. To ensure further a null allele, a stop 
codon was engineered at a position in the itk gene corre- 
sponding to amino acid 78, upstream of the deleted exons 
(Figures 1A and 1 B). The itk mutation was introduced into 
the mouse genome by standard techniques using the Jl 
embryonic stem (ES) cell line, which was derived from 
the mouse strain 129/Sv (Li et al., 1992). Homologous 
recombination at theitklocus wasdetected by polymerase 
chain reaction (PCR) and confirmed by Southern blot anal- 
yses using the 5’ and 3’ probes (Figures 1 B and 1 C; data 
not shown), both of which lie external to the homologous 
regions in the gene-targeting construct. The targeted ES 
cells were used for blastocyst injection. The chimeric ani- 
mals generated were subsequently back-crossed to C57BU 
8J mice and agouti progeny bearing the targeted itk allele 
were interbred for homozygosity of the targeted allele. 
Thymocytes from the wild-type mice were lysed and im- 
munoblotted with rabbit antisera specific for Itk. Murine 
Itk exhibits an apparent molecular mass of 72 kDa (Figure 
lD, lane 5; see also Siliciano et al., 1992). No Itk protein 
product was detected in thymocytes from mice homozy- 
gous for the mutated itk gene (Figure 1 D, lane 7). More- 
over, thymocytes from heterozygous mice exhibited levels 
of Itk approximately half relative to normal mice (Figure 
lD, lane 8). The location of Itk on the SDS-PAGE gels 
was confirmed by analyzing COS cells transfected with 
full-length murine itk cDNA (Figure 1 D, compare lanes 3 
and 4 with lanes 1 and 2). Two different rabbit polyclonal 
antisera, ItkN4 and ltkCL45, were used for Western blot 
detection of Itk and gave similar results (data not shown 
for ltkCL45). 
To investigate whether truncated forms of the Itk protein 
bearing epitopes recognizable by one but not the other 
Itkantiserum were produced in it/c- mice, Itk was immuno- 
precipitated from thymocyte lysates with ItkN4 and was 
detected by immunoblotting with ItkN4 or ltkCL45. Under 
such conditions, thymocytes from the wild-type mice gave 
rise to a single protein band with a molecular mass of 
72 kDa (Figure 1 E; data not shown). Reciprocally, using 
ltkCL45 for immunoprecipitation followed by blotting with 
ltkCL45 or ItkN4 also gave the same result (data not 
shown). Mice homozygous for the targeted allele of itk had 
no detectable Itk protein of any size by immunoprecipita- 
tion and immunoblotting (Figure 1 E, lanes 5 and 8). Thus, 
the mutation of itk represents a null allele. 
T Cell Development in the Absence of Itk 
Itk-deficient mice were viable and fertile, and had no evi- 
dence of gross developmental defects. The total number 
of thymocytes in mutant mice was similar to that in hetero- 
zygous or wild-type littermates (Table 1). Moreover, the 
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Figure 1. Targeted Disruption of the itk Gene 
(A) Comparison of intron placement in the mu- 
rine Ilk and Bt/r genes. Exon 1 of the mouse 
i&gene is shown here to contain the translation 
initiation codon. Mouse and human Btk have 
the same organization for intron/exon bound- 
aries and the initiation codon was found to be 
in exon 2 of Btk (Rawlings et al., lsg3; Ohta 
et al., 1994; Hagemann et al., 1994; Sideras 
etaf.,1994;Rohreretal.,1994).TheAOandA1 
denote the type of intron boundary (between 
codons, or after the first nucleotide of the co- 
don, as indicated with a vertical bar). The con- 
served amino acids between Itk and Btk are 
shown in bold and gaps in the amino acid se- 
quences are represented by dashes. The 8 ex- 
tra amino acids in the longer isoform of the 
murine ihk cDNA are underfined. The position 
of the stop codon in the MI gene-targeting con- 
struct is shown with an asterisk above Tyr78. 
(B) Partial restriction map of the Mk gene. Both 
the wild-type allele and the targeted allele of 
if/r are shown, together with a diagnostic 
scheme for their differentiation. The horizontal 
lines refer to introns, and boxes refer to exons. 
The fragments involved in homofogous recom- 
bination are represented with thick lines. Re 
striction sites unique to the targsted allele of 
it& are circled. The arrowheads indicate prlm- 
ers for PCR screening of homologous recombi- 
nation in the ES cells. The external probes (5’ 
probe and 3’ probe) used in Southern blot anal- 
ysis to confirm homofogous recombination and 
to screen for mice with the itk gene disruption are indicated with hatched boxes. Asterisk, an in-frame stop codon created in the targeted allele 
of iti. B, BamHI; H, Hindlll; X. Xbal. 
(C) Analysis of tail DNA samples from mice derived from an ES clone carrying the disrupted allele of the if/r gene (with the designed stop codon 
at exon 2) using the 5’ probe. After Hindlll digestion, the wild-type allele of itk is represented by the top band (25.1 kb) and the mutant allele by 
the bottom band (17.8 kb). 
(D) Western blot analysis of Itk in COS cell or thymocyte lysates. COS cells were transiently transfected with expression vectors without (lanes 
1 and 2) or with the full-length cDNA of murine it/c (lanes 3 and 4). Thymocytes were from mice with the following genotypes at the if/r locus: +I+. 
lane 5; +I-, lane 8; and -/-. lane 7. Antiserum ItkN4 (against amino acids 1-175 of ltk) was used at 15000 in TBST with 5% nonfat dry milk. 
Similar results were obtained with antiserum ltkCL45 (against amino acids 175-819 of Itk). The position of Itk is indicated (lower band in the 
doublet). 
(E) lmmunoprecipitation and Western blot analysis of Itk in thymocyte lysates. Thymocyte lysates from if/V mice (lanes 1, 2, 3, and 4) were 
immunoprecipitated with ItkN4 (Lanes 2, 3, and 4) or preimmune serum from the same rabbit (lane 1). Thymocyte lysates from it/r- mice (lanes 
5 and 8) were immunoprecipitated with ItkN4. The immune complex was resolved by 7.5% SDS-PAGE with reducing agent and blotted for Itk 
with ltkN4. The position of Itk is indicated. Rabbit immunoglobulins account for the strong background signal. 
percentage of double-negative (DN) and DP thymocytes heterozygous or wild-type littermates (Table 1; Figure 2A). 
was comparable in all the mice (Table 1). However, the This suggested that development of CD4 SP thymocytes 
ratio of CD4 SP versus CD8 SP thymocytes in I&-‘- mice was more sensitive to the lack of Itk than that of CD8 SP 
was reduced 2- to 3-fold when compared with the ratio in thymocytes. Although the overall cell numbers in lymph 
Table 1. T Cell Populations in the Thymus and Lymph Nodes of Itk-Deficient Mice’ 
Total Cells Percentage of Total T cells* 
Percentage of Total Cells (%) 
CD4lCDS 
Genotype Source x 10-r T Cells (%) x 10-7 CD4-CDS- CD4+CDS+ CD4+CDS- CDCCDS’ Ratio 
itk+‘+ (n = 2)b Thymus 25.5 A 10.8 2.3 f 0.1 80.5 f 3.0 12.0 f 1.7 5.2 f 1.2 2.3 f 0.2 
itk”- (n = 5)b Thymus 20.2 f 7.8 2.8 f 0.8 82.8 f 2.8 10.4 f 1.4 4.2 f 1.1 2.8 * 0.4 
it/r- (n = 8)b Thymus 18.8 f 8.9 3.2 f 0.7 79.8 zt 3.2 7.9 f 0.8 9.1 f 3.4 0.9 * 0.3 
it/r+‘+ (n = 8) Lymph nodesd 5.2 f 2.1 75.5 f 8.3 3.7 f 1.5 4.4 + 2.9 0.5 f 0.2 50.9 f 4.7 19.7 f 7.8 3.3 f 2.4 
it/r+- (n = 14)c Lymph node@ 5.1 zt 2.0 70.8 f 8.4 3.8 f 1.2 3.5 Et 1.3 0.4 f 0.2 45.1 f 8.4 21.7 f 5.8 2.4 f 1.5 
irlr’- (n = 18)c Lymph nodes” 4.7 f 4.2 47.1 f 12.4 1.9 f 1.7 8.4 f 2.3 0.2 f 0.1 21.2 f 8.2 19.4 f 7.9 1.2 f 0.4 
n Data are expressed as mean f standard deviation. 
b Mice, 5-8 weeks old; numbers of animals studied are shown in parentheses. 
c Mice, 3-t 3 weeks old; numbers of animals studied are shown in parentheses. 
d Cervical; brachial; axillary; superficial inguinaf, and mesenteric. 
e The number of T cells in the lymph nodes was calculated based on the percentages of cells staining positive with antiCDh. 
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nodes and spleens remained unchanged, the number of 
T cells was reduced by 15 to P-fold in ltkdeficient mice, 
compared with that in heterozygous or wild-type lit- 
termates (Table 1). The number of B cells was increased 
correspondingly in Itkdeficient mice, asjudged by staining 
with the B cell markers 8220 (Figure 28) and IgM (data 
not shown). Consistent with the reduced ratio of mature 
CD4+ versus CD8+ thymocytes in the homozygous mutant 
mice, the number and proportion of CD4+ T cells in the 
periphery suffered a moresevere reduction compared with 
that of the CD8+ T cells (Table 1). 
Responses of T Cells from ltk-Deficient Mice to 
Allogeneic MHC Challenge 
To determine whether T ceils that appear in the periphery 
of Itk-deficient mice are functional, we assayed their prolif- 
eration in response to allogeneic stimulation. To adjust 
for the difference in the number of mature T ceils from 
ifk’- and control if/P’- littermates, lymph node cells de- 
pleted of B cells and CD8+ T cells were used as responder 
ceils in these assays. They contained about 90% CD4+ T 
ceils with similar surface TCR level, and were of the H-2b 
haplotype. When tested in mixed lymphocyte reaction 
Figure 2. Thymue and Lymph Node Profiles of 
Itk-Deficient Mice 
Flow cytometric analyses of thymcqtes (A) 
and lymph node cells (2) from 5weekold wild 
type (HP+), heterozygous (ilk”), and homozy- 
gous (rtrcl-) llttetmates stalned with an&CM 
and anti-CD& or anti-CDS and anti-2220. Per- 
cent of total cells in each quadrant is indicated. 
(MLR) with irradiated BALB/c splenocytes (H-P), the CD4’ 
T cells from the homozygous mutant mice showed signifi- 
cantly reduced proliferation compared with heterozygous 
littermates (Figure 3). Separately purified CD4+ and CD8+ 
cells from Itkdeficient mice and control littermates were 
also challenged with irradiated splenocytes from the 
mouse strains B8.H-2bm12 (class II mutant) and B8.H-2bm1 
(class I mutant), respectively. Reduced proliferation was 
observed with both CD4+ and CD8+ cells from Itkdeficient 
mice compared with the control mice (data not shown). 
Taken together, these data indicate that T cells in the pe- 
ripheryof itkdeficient mice are compromised in their prolif- 
erative responses elicited by ailoantigenic stimulation. 
TCR-Mediated Proliferative Responses in 
ltk-Deficient Mice 
To characterize further the cell proliferation defect in Itk- 
deficient animals, CD4+ T cells were stimulated with con- 
canavalin A (ConA) or anti-CD3 antibodies in the presence 
of irradiated syngeneic splenocytes. Significant reduction 
in proliferative responses to both stimuli was observed 
with cells from the mutant mice compared with those from 
control littermates (Figures 4A and 48). However, cells 
T Cell Phenotype in Itk-Deficient Mice 
761 
2 -- + I&-, with BALE/c 
ii 
--& Id-, with BALBk 
+ ltk +I-, with C57BlJB 
.E -- 






E 1 //I 
jyyd 
0 1 2 3 4 
# of Responders x 1W5 
Figure 3. Proliferative Response towards Allogeneic MHC 
CD4+ lymph node cells from mice of the indicated genotypes (W-, 
solid lines; and iti-‘-, broken lines) were stimulated in vitro with irradi- 
ated splenocytes from C57BU6 mice (squares) or from BALBlc mice 
(triangles). Cell proliferation was measured by PHjthymidine incorpora- 
tion. Standard deviations for triplicate samples are shown as error 
bars along they axis, some of which may be not apparent due to their 
small values. 
from itk+ mice and itk+‘- mice responded similarly to phor- 
bol myristate acetate (PMA) and ionomycin (Figure 48). 
These data suggest that T cells lacking Itk are compro- 
mised in a relatively early phase of the TCR-mediated sig- 
naling pathway. 
Based on induction of itk mRNA in CTLL-2 cells with 
IL-2, it was suggested that Itk may mediate IL-2R signaling 
(Siliciano et al., 1992). To look at T cell reactivity to IL-2, 
exogenous IL-2 was added to the culture together with a 
submitogenic dose of ConA. Under such conditions, both 
irk’- and iW- cells responded to addition of exogenous 
IL-2 with enhanced proliferation (Figure 4C). These data 
indicate that Itk is not essential for IL-2R signaling and 
suggest that reduced production of IL-2 by irk’- T cells 
may be a primary reason for their reduced proliferation. 
Effect of Loss of Itk on T Cell Development in TCR 
Trenegenic Mice 
Mice expressing specific transgenic TCRs have provided 
valuable insight into the mechanisms of positive and nega- 
tive selection and the role of individual gene products in 
these processes. To determine whether Itk has a role in 
the selection of T cells having a single specificity, we intro- 
duced transgenic TCRs specific for either MHC class II 
or class I into the Itk-deficient background. 
Positive Selection of T Cells Expressing Class 
/l-Restricted 7CR Transgenes 
AND TCR transgenic mice express a TCR that is specific 
for pigeon cytochrome C (PCC) bound to the MHC class 
II molecule I-Ek (Kaye et al., 1989). Positive selection of 
AND T cells in the H-2k or H-2b background results in the 
appearance of mature T cells that are virtually all CD4 SP 
and express high levels of both transgenic TCR a and 8 
A 
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Figure 4. Cell Proliferation Induced by TCR Stimulation 
Purified CD4’ lymph node cells were stimulated with ConA (A) or puri- 
fied anti-CD3 (B) at the indicated concentrations, or with PMA (1 ngl 
ml) and ionomycin (500 nglml) (B). Alternatively, they were stimulated 
with 0.125 pg/ml ConA plus indicated concentrations of human recom- 
binant IL-2(C). Cell proliferation was measured by PH]thymidine incor- 
poration. Standard deviations for triplicate samples are shown as error 
bars along the y axis. 
polypeptides (Kaye et al., 1992). In the absence of Itk, 
there was a dramatic reduction in the proportion and num- 
bers of CD4+CD8- thymocytes in the AND TCR transgenic 
mice (Figure 5A; Table 2). Consistent with the phenotype 
observed in the thymus, in the periphery of if/c’- AND TCR 
mice there was a profound reduction in the number of 
CD4+ T cells (Table 2; Figure 58). The few CD4+ cells that 
developed in the mutant mice had a significant reduction 
in expression of the TCR a chain (40%-50% versus more 
than 90% in heterozygous littermates), suggesting that 
these cells were selected due to expression of endoge- 
nous TCR a chains (Figure 58). Concomitant with the re- 
duction in CD4’ T cells; there was a 5- to 7-fold increase 
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To ask whether Itk also affects development of CD8 lin- 
eage cells, we studied positive selection of T cells express- 
ing class l-specific TCR transgenes in the Itkdeficient 
background. Thymocyte development is skewed towards 
the CD8 lineage in female H-2b mice expressing a 
transgenic TCR specific for the male-specific H-Y antigen 
and the class I molecule Db (von Boehmer, 1990). This 
skewing is not as dramatic as it is for the CD4 lineage 
in the AND mice; nevertheless, selection of thymocytes 
bearing the clonotypic TCR can be followed using the 
T3.70 monoclonal antibody (Teh et al., 1988,1989). In the 
absence of Itk, there was a decrease in the efficiency of 
selection of CD4-CD8+T3.70hi thymocytes (Figure 6A). 
This effect was particularly evident in the periphery of 
these mice, where the number of CD4CD8+ T cells bear- 
ing the clonotypic TCR was greatly reduced despite little 
difference in the total number of CD4CD8+ cells (Figure 
6B; Table 2). Mature CD4+ T cells appear in the periphery 
of H-Y transgenic mice due to rearrangement at the en- 
dogenous TCR a locus (von Boehmer, 1990). In female 
if/P H-Y mice, selection of both the CD4 and CD8 T cell 
lineages thus favored cells that utilized endogenous TCR 
a chains. 
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compared with the control AND TCR mice (Table 2). These 
CD4CD8- T cells also expressed the transgenic TCR a 
and 5 polypeptides (Figure 58; data not shown). These 
data suggest that Itk is involved in development of CD4’ 
T cells. Its absence dramatically changed the develop- 
mental outcomes of T cells bearing a defined TCR, re- 
sulting in appearance of only a few CD4+ cells, most of 
which had lost expression of the clonotypic receptor, or 
of cells that had lost coreceptor expression but retained 
expression of the transgenic TCR. 
Positive Selection of T Cells Expressing Class 
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Figure 5. Absence of Itk Interferes with Development of CD4 Lineage 
Cells in AND Transgenic.Mice 
(A) Thymocytes from AND transgenic Mr+- and AND transgenic if/r- 
mice (both H-p) were stained with antiGD4, antiCD6, and anti-Val 1, 
which recognizes the transgenic TCR a chain. Expression of CD4 and 
CD8 is shown as dot plots (top). Percent Of total cells in each quadrant 
is indicated. CD4+CD8- cells in the upper,left quadrant were electroni- 
cally gated to show expression of the transgenic TCR a chain (Vail 
histogram, bottom). Proportion of Val I+ cells (as marked by Ml) in 
the gated population is indicated. 
The number of CD4’ T cells in the periphery of female 
irk’- H-Y TCR mice was reduced compared with heterozy- 
gous (ifP) H-Y TCR littermates (Figure 6B; Table 2), indi- 
cating that development of CD4+ T cells in general contin- 
ued to be affected by the absence of Itk. This is consistent 
with phenotypes found in nontransgenic it/c- as well as 
it/c- AND TCR mice. In contrast with it/r-‘- AND TCR mice, 
the number of DN T cells in the periphery of female it/r’- 
H-Y TCR mice was not significantly different from that of 
if/r+‘- H-Y TCR mice or from nontransgenic mice (Table 2; 
data not shown). 
Negative Selection of Thymocytes Expressing the 
H-Y-Specific TCR Transgenes 
The H-Y transgenic mice also provide a system to ask 
whether Itk is involved in negative selection of thymocytes. 
In male transgenic mice, thymocytes expressing the H-Y- 
specific transgenic TCR interact with the male-specific an- 
(B) Lymph node cells of the AND transgenic it/r+- and AND transgenic 
if/r+ mice (both H-29 were stained with antiCD4, anti-CD& and anti- 
Val 1 as in (A). Expression of CD4 and CD8 (top), as well as expression 
of CD4 and Val 1 (bottom), is shown as dot plots. Percent of total cells 
in each quadrant is indicated. The lower right quadrant of the bottom 
panel contains cells that were CD4-CD6-Vail’. 
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Table 2. T Cell Populations in the Thymus and Lymph Nodes of the AND TCR and H-Y TCR Transgenic Mice’ 
Total T cells* CDCCDB- CD4’CDB’ CD4+CD0- CDKCD8’ 
Genotype Source x 10-7 x lo+ x10-’ x10* x10* 
AND transgenic, it/r+- (n = 3)b Thymus 20.7 f 3.8 14.2 f 1.3 10.4 f 2.7 79.1 f 15.7 9.2 f 5.4 
AND tranegenic, if&- (n = 8y Thymus 18.2 f 9.6 23.4 f 12.0 14.6 k 8.0 9.3 f 7.1 3.7 f 3.0 
AND transgenic, if/f- (n = 3)” Lymph nodesd 3.7 f 2.3 3.5 f 3.6 - 31.0 f 18.5 1.3 f 0.5 
AND transgenic, if/r- (n = 8)b Lymph nodesd 3.4 f 1.5 24.2 f 12.8 - 5.9 f 2.7 3.7 f 2.2 
H-Y transgenic, if/@ (F, n = 4) Thymus 20.2 f 7.2 11.5 f 7.6 13.4 f 6.7 21.6 f 11.4 34.6 f 13.0 
H-Y transgenic, if/r- (F, n = 4) Thymus 15.5 f 6.7 16.1 f 12.0 11.2 f 6.0 11.4 f 6.5 15.8 f 10.5 
H-Y transgenic, it/@ (F, n = 4) Lymph node& 3.6 f 0.9 1.0 f 1.2 - 23.9 f 7.2 10.5 f 1.0 
H-Y transgenic, it/r- (F, n = 4) Lymph nod& 1.9 f 0.6 2.7ztl.5 - 9.4 f 2.9 6.7 f 1.6 
H-Y transgenic, if/r+- (M, n = 5)” Thymus 2.2 f 0.9 15.9 f 7.3 0.10 f 0.07 3.7 zt 1.6 1.7 f 0.9 
H-Y transgenic, it@- (M, n = 4)’ Thymus 3.0 f 1.4 13.7 f 7.7 0.68 f 0.36 4.9 f 0.8 4.9 f 3.7 
H-Y transgenic, iW- (M, n = 5) Lymph node@ 1.5 f 0.3 9.1 f 3.5 - 0.8 f 0.3 5.1 f 1.6 
H-Y transgenic, irks- (M, n = 4) Lymph nodesd 1.2 f 0.3 3.9*1.3 - 1.2 f 0.5 6.6 f 2.6 
’ Data are expressed as mean f standard deviation. Dashes indicate negligible numbers with no significant difference among the animals. 
b Mice, 8-10 weeks old; numbers of animals studied are shown in parentheses. 
c Mice, 8-10 weeks old; the sex and numbers of animals studied are shown in parentheses. F, female; M, male. 
@ Cervical, brachial, axillary, superficial inguinal, and meeenteric. 
a The number of T cells in the lymph nodes was calculated based on the percentages of cells staining positive with anti-CD&. 
tigen presented by H-2Db, resulting in early negativeselec- 
tion. Deletion in the TCR transgenic mice is accompanied 
by a large decrease in the size of the thymus, primarily 
owing to a reduction in the total number of CD4+CD8+ 
thymocytes (von Boehmer, 1990). Although there was a 
consistent increase in the fraction of CD4+CD8+ thymo- 
cytes in male H-Y transgenic it/r-‘- mice compared with 
H-Y transgenic it/f+- mice (Figure 7; Table 2) the total 
number of thymocytes was unaffected (Table 2). In the 
periphery of male H-Y transgenic mice, self-reactive CD8+ 
T cells escape clonal deletion by down-modulating CD8 
expression (Teh et al., 1989). This population of lymph 
node T cells was also present in mice lacking Itk, and no 
CD4-CD8hiT3.70+ cells were observed (data not shown). 
These results suggest that Itk does not play a major role 
in negative selection of self-reactive thymocytes. 
Discussion 
Signaling pathways following activation of thymocytes and 
T lymphocytes remain incompletely understood. Although 
there is general consensus that early signaling involves 
the activity of Src family PTKs and of ZAP-70, it is not yet 
clear how downstream effector pathways are accessed 
and modulated. Moreover, it remains unclear what types 
of signaling difference are involved when activation of thy- 
mocytes results in different developmental outcomes, 
such as positive selection versus induction of programmed 
cell death (reviewed by Rothenberg, 1994). Lck is required 
for effective TCR-mediated T cell activation (Straus and 
Weiss, 1992; Karnitz et al., 1992) and for expansion of 
CD4+CD8+ thymocytes in thymocyte development (Molina 
et al., 1992; Mombaerts et al., 1994). ZAP-70 is required 
later, for the progression of DP thymocytes to mature T 
cells (Arpaia et al., 1994; Negishi et al., 1995). In this re- 
port, we have explored the role of ltk, a member of a third 
class of cytoplasmic PTKs that is expressed in T lympho- 
cytes, in T cell activation and development. We have 
shown that mice lacking Itk have a moderate reduction in 
the number of mature T cells, particularly CD4 SP cells. 
This effect was dramatically magnified when we analyzed 
development of T cells with a defined transgenwncoded 
TCR. Furthermore, mature T cells in the ltk-deficient mice 
were impaired in their proliferative responses to allogeneic 
MHC, anti-CD3 antibodies, and ConA. This study hence 
identifies Itk as another PTK with an important role in T 
lymphocyte signal transduction. 
A Partial Block of T Cell Development 
in Itk-Deficient Mice 
Itk-deficient mice had reduced numbers of mature thymo- 
cytes and lymph node T cells, as well as a reduced ratio 
of CD4 to CD8 SP cells in thymus and, to a lesser degree, 
in the periphery. This could reflect either reduced produc- 
tion or reduced survival of mature T cells in the absence of 
Itk. Although a more complete developmental block might 
have been expected based on the effects of Btk mutations 
in human XLA patients, a partial block in T cell develop- 
ment in Itk-deficient mice more closely resembles the mild 
phenotypes of Btk mutations in mice. xid mice with a point 
mutation in the PH domain of Btk, as well as mice with a 
targeted insertional mutation in the Bfk gene (Khan et al., 
1995) have only a moderate reduction in numbers of ma- 
ture B cells, but these cells are defective in their prolifera- 
tive responses to surface immunoglobulin cross-linking 
(Mond et al., 1983; Khan et al., 1995). The partial block 
in T and B cell development in mice that have defects 
in Itk and Btk, respectively, may be due to overlapping 
functions of related PTKs expressed in these cells. For 
example, Tee, the other member of this family of PTKs, 
was shown to be expressed in thymus(Mano et al., 1993). 
Since these and potentially other family members may 
compensate for the absence of Itk, it will be important to 
study mice defective for two or more members of this fam- 
ily of kinases. 
Development of T Cells with Tranegenic TCRs 
in the Absence of Itk 
The absence of Itk had a much more profound effect on 
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Figure 7. Clonal Deletion of the H-Y-Specific TCR in the Absence 
of Itk 
Thymocytes from male H-Y transgenic it/r+ or itk’- mice (both 
H-2”) were stained with antiCD4, anti-CD& and biotinconjugated 
T3.70. specific for the transgenic TCR a chain. Expression of CD4 
and CD3 is shown as dot plots (top). Percent of total cells in each 
quadrant is indicated. Expression of the self-reactive transgenic TCR 
on total thymccytes is shown at the bottom. 
B 
H-Y Tg, itk +‘- H-Y Tg, Itk -I- 
Lymph Node 
encoded TCR than on the broad repertoire of T cells. In 
mice expressing the class II-restricted AND receptor, loss 
of Itk resulted in a reduction of more than 80% of mature 
CD4+ T cells (Table 2; Figure 58). The loss may be due 
to an early block in the transition from DP to SP thymocytes 
(Figure 5A). Loss of Itk may thus result in reduced signal 
transduction upon TCR engagement, with decreased pro- 
liferative capacity as well as reduced positive selection of 
CD4+ thymocytes. 
Alternative explanations are suggested by the observa- 
tions, in the periphery of it/r’- AND TCR mice, that most 
of the remaining CD4CDS cells have lost expression of 
transgenic TCR and that there is a significant increase in 
the number of CD4CD8- cells expressing the transgenic 
TCR (Figure 58). CD4CD8- T cells expressing the 
transgenic TCR may represent a lineage distinct from con- 
ventional TCRa5 T cells. Similar DN populations in other 
TCR transgenic mice appear to be independent of positive 
CM‘CDa+ Lymph Ncde Cells 
recognizes the transgenic TCR a chain. Expression of CD4 and CD3 
is shown as dot plots (top). Percent of total cells in each quadrant is 
indicated. In each case, CD4CD8’ cells in the lower right quadrant 
were electronically gated to show expression of the transgenic TCR 
as stained with T3.70 (bottom). Proportion of T3.70’ cells (as marked 
by Ml) in the gated population is indicated. 
Figure 6. Positive Selection of CD8 Lineage Cells in the Absence 
of Itk 
Thymocytes (A) and lymph node cells (6) from the female H-Y 
transgenic it/r+- and H-Y transgenic itk-‘- mice (both H-2”“) were 
stained with antiCD4, anti-CD& and biotin-conjugated T3.70, which 
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or negative selection (Russell et al., 1989; Robey et al., 
1992a). The lack of Itk may then serve to reveal an other- 
wise underrepresented lineage in T cell development. 
Another alternative explanation derives from compari- 
son with observations of DN T cells in transgenic mice 
that express a self-reactive transgenic TCR (Schonrich et 
al., 1991) or that overexpress a coreceptor in combination 
with acognate TCR (Lee et al., 1992; Robeyet al., 1992b; 
Davis and Littman, 1995). In the latter cases, increased 
avidity due to the contribution of coreceptor to TCR interac- 
tions with MHC can result in negative selection; loss of 
either the coreceptor or of the TCR can apparently allow 
for positive selection of the thymocytes. Our observation 
of CD4-CD8- T cells expressing transgenic TCR in the 
periphery of itk’- AND TCR mice therefore raises the pos- 
sibility that the decrease in CD4 lineage cells in it/@- AND 
TCR mice is due to increased TCR signaling during devel- 
opment in these animals. Itk may thus normally down- 
modulate TCR signals and its absence may allow en- 
hanced negative selection. However, there was no 
obvious enhancement of CD3-mediated signal transduc- 
tion in thymocytes from Itk-deficient mice, as measured by 
proliferation and accumulation of intracellularfreecalcium 
(data not shown). Moreover, there was no apparent differ- 
ence in the proportion of DN to DP thymocytes between 
control and Itk-deficient animals (Table l), and lack of Itk 
did not result in increased negative selection in male H-Y 
transgenic mice, which takes place early in thymocyte de- 
velopment. Therefore, for this scenario to be correct, en- 
hancement of negative selection would have to occur in 
a narrow window late in thymic development. 
In mice transgenic for the MHC class l-specific H-Y 
TCR, there is positive selection of clonotype-positive 
CD4-CD8+ thymocytes in female mice of the appropriate 
MHC background. However, in contrast with the AND 
mice, a large proportion of developing thymocytes in the 
female H-Y mice are also selected on the basis of expres- 
sion of endogenous TCR a chains. In the absence of Itk, 
there was dramatic loss of the CD8 lineage thymocytes 
and mature T cells expressing the T3.70+ clonotypic TCR, 
but apparently normal development of CD8 lineage cells 
that utilize endogenous TCR a chains (Figure 6). This re- 
sult may be due to a defect in positive selection of CellS 
expressing the transgenic TCR in the absence of Itk. Alter- 
natively, based on the results in the AND transgenic mice, 
this could be due to enhanced negative selection, oc- 
curring late in thymocyte development, of cells expressing 
the clonotypic TCR. In the AND mice, this would be mani- 
fested by a dramatic decrease in the CD4 SP population 
and an increase in clonotype-positive DN T cells; in the 
H-Y mice, this could result in appearance of only clono- 
type-negative cells. 
Role of Itk in T Cell Signal Transduction 
T cells from Itk-deficient mice had reduced proliferative 
responses to allogeneic MHC stimulation and to TCR 
cross-linking. Since these cells proliferated as well as cells 
from control mice in response to PMA and ionomycin, 
which bypass stimulation of cell surface components, Itk 
appears to be involved in membrane-proximal events in 
T cell activation, downstream of a TCR-initiated signal. 
Earlier studies have suggested that Itk may be involved 
in other signaling pathways. There was an increase in itk 
mRNA upon treatment of CTLL-2 cells with IL-2 (Siliciano 
et al., 1992), suggesting a possible role for Itk in IL-2 recep 
tor signaling or IL-2-dependent effector functions. We 
found that the decreased proliferative response of Itk- 
deficient T cells to ConA was completely rescued by addi- 
tion of exogenous 11-2, indicating that Itk is not required 
for signaling through the cytokine receptor. Itk has also 
been shown to be coprecipitated with CD28 and to become 
phosphorylated following CD28 cross-linking (August et 
al., 1994); it has thus been postulated that Itk has a key 
role in CDS&mediated costimulation. In preliminary stud- 
ies, we have found that the CD28 signaling pathway is not 
impaired in T cells from the Itkdeficient mice (X. C. L., S. 
Fournier, J. Allison, and D. R. L., unpublished data). In 
addition, ltk-deficient mice have a phenotype distinct from 
that of CD28deficient mice. For example, unlike Itk- 
deficient animals, mice lacking CD28 have normal T cell 
development, with normal numbers of mature T cells in 
the periphery (Shahinian et al., 1993). In addition, CD2& 
deficient mice have abnormal immunoglobulin isotypes, 
which were not observed in Itkdeficient mice (unpublished 
data). 
Our results are consistent with a role for Itk in efficient 
TCR-mediated signaling that results in proliferative re- 
sponses. However, our analysis of mature T lymphocytes 
employed cells that had undergone thymic selection in the 
absence of Itk. We must, therefore, consider the possibility 
that reduced responses of Itk-deficient T cells may reflect 
a compensation that permits selection of these cells. If Itk 
normally delivers a down-modulatory signal during T cell 
development, as was suggested above, positive selection 
of Itk-null thymocytes may only be achieved by cells that 
have compensated; for example, alteration in the concen- 
trations of components of intracellular signaling pathways 
may be essential for Itk-null cells to be selected for comple- 
tion of maturation, but would result in reduced signaling 
in mature T cells. 
The phenotypes that we observe in Itkdeficient mice 
may be parallel to some degree to the effect of Btk muta- 
tions in B cell development. In XLA patients, the number 
of bone marrow pre-B cells is normal, but there is impaired 
maturation to the B cell stage. This could be due to a 
developmental arrest or to exaggerated cell death at the 
pre-B to B-cell transition (Tsukada et al., 1993; Pearl et 
al., 1978). In xid mice, in which this effect is more subtle, 
it remains unclear why some B cells mature whereas oth- 
ers do not. Thymocytes in Itkdeficient mice appear to de- 
velop normally to the DP stage, but then display a defect 
in their transition to mature T cells. To better understand 
the function of Itk, it will be important to determine the 
nature of the mature T cells in the irk’- mice. An analysis 
of the TCR repertoire in mutant and control mice may 
shed some light on the mechanism by which Itk influences 
development of the immune system. It will also be im- 
portant to determine whether these T cells are selected 
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by a novel mechanism in the absence of Itk. Our studies 
using TCR transgenic mice in the Itk-deficient background 
have provided important clues to address these questions. 
In summary, we have identified Itk as an important PTK 
involved in T cell develooment. Itk may be involved in reou- 
lation of the threshold of signal transduction during deiel- 
opment. One possibility is that Itk amplifies a positive sig- 
nal from the TCR complex. In its absence, there would 
be a decrease in signal intensity, resulting in reduced effi- 
ciency of positive selection and reduced T cell proliferation 
upon TCR stimulation. Alternatively, Itk may deliver or am- 
plify an inhibitory signal. In its absence, there would be 
increased signal intensity, resulting in negative selection 
of cells that would otherwise undergo positive selection. 
The latter interpretation implies that mature T cells in 
if/r-‘- mice would have down-modulated the strength of 
signals to survive, which is consistent with their reduced 
proliferation upon TCR stimulation. Understanding the 
biochemical pathways in which Itk is involved will help to 
resolve these issues. 
leaving a small portion of each to grow without feeder cells for DNA 
preparation as described (Laird et al., 1991). 
PCR Analysis of ES Cells 
Screening of ES cells carrying homologous recombination was 
achieved by PCR as described previously (Stein et al., 1992; Soriano 
et al., 1991). ES cells from a pool of 6 clones or from a single clone 
were centrifuged and resuspended in 12 pl of the PCR lysis buffer 
(16.6 mM ammonium sulfate, 67mM Tris-HCI [pH 6.6],6.7mM MgCb, 
5 mM 5-mercaptoethanol, 6.7 PM EDTA, 1.7 pM SDS, and 50 ug/ml 
proteinase K). The cells were lysed for 1 hr at 37OC followed by heat 
inactivation of proteinase K at 65OC for 10 min. The debris were spun 
down, and 5 ul of the supernatant was used for PCR reaction in a 
final volume of 25 pl. The reaction buffer for the PCR was as follows: 
1 x PCR buffer (PCR lysis buffer without SDS and proteinase K), 1 
mM each dNTP, 10% DMSO, 60 kg/ml bovine serum albumin 
(nuclease free), 0.1 pM each oligonucleotide primer, 2.5 U Taq poly- 
merase (Boehringer Mannheim), and DNA provided by 5 ul heat- 
inactivated cell lysate. Usual PCR conditions were 93OC for 2 min, 
then 40 cycles at 93OC for 1 min, 56OC for 1 min. and 65OC for 5 
min. using the DNA Thermal Cycler 4600 (Perkin Elmer). The oligo 
nucleotides used were the following: 3’neo, B’CTTGACGAGTTCTTC- 
TGAGGGGA-3’; andiUrPCRintron4-, 5%GGATGCCAGAATCAAClT- 
TGGTAG-3’. 
Experimental Procedures 
Construction of the Targeting Vector 
A modified version of the neo cassette, pgk(G)neopA, was obtained 
by swapping the Eagl to BamHl fragment of pKJ1 (Tybulewicz et al., 
1991) with that of a new version of pMClneo Poly(A) (Stratagene), 
which contains the correct coding region of the neomycin phospho- 
transferase II gene (Yenofsky et al., 1990). The resulting pgk(G)neopA 
cassette contained the promoter and enhancer elements from the mu- 
rine pgk-7 gene followed by the correct nsc coding region and the 
poly(A) addition site from the thymidine kinase gene (t/r) of the Herpes 
simplex virus (H. Boeuf, personal communication). The pgk(G)neopA 
cassette was subcloned into pBluescript KS(+) to generate pBSneo 
(hf. E. C. Crooks, personal communication). 
it/r- mice were differentiated from if/r+- or irk+‘+ mice by Southern blot 
analysis. The 5’ probe was a 240 bp fragment internal to the putative 
intron 1. With the 5’ probe, the wild-type allele of itk was detected as 
a 25.1 kb Hindlll fragment and the mutant allele as a 17.6 kb Hindlll 
fragment. The 3’ probe was a 2.35 kb Hindlll-EcoRV fragment con- 
taining the putative introns 4 and 5 and exon 5. With the 3’probe, the 
wild-type allele of itk was detected as a 35 kb BamHl fragment and the 
mutant allele as a 3.65 kb BamHl fragment. Both probes are external to 
the targeting construct. 
Expression of itk In COS Cells 
A 400 bp Pvull-Pvull cDNA fragment encoding the N-terminal part 
(except the first 10 aa) of the murine Itk protein was used to screen 
a mouse genomic library in the 5DASH II vector (gift of Dr. P. Soriano, 
Fred Hutchison Cancer Center, Seattle, Washington). A stop codon 
was engineered at amino acid 76 of Itk within the putative exon 2 
concomitant with an introduction of a Hindlll site. A 6.6 kb Xbal- 
Eco47lll fragment encompassing the mutated exon 2 was ligated onto 
the 5’end of pgk(G)neopA and a 1.9 kb Apal-Hindlll fragment internal 
to intron 4 of the itk gene was blunt-end ligated onto the 3’ end of 
pgk(G)neopA. The orientation of pgk(G)neopA was the same as the itk 
gene in the gene-targeting construct. The targeting vector was named 
pltkSTOP/KO/pgk(G)neopA, which was linearized with Notl before 
transfecting ES cells. 
A 200 bp fragment identical to the murine itk cDNA was cloned by 
RT-PCR in the course of a screen that employed degenerate oligonu- 
cleotides to identify non-Src family PTKs from mouse thymus (Lai and 
Lemke, 1991). This fragment was used to screen a murine thymocyte 
cDNA library. A partial cDNA clone containing the 3’portion of the itk 
cDNA was obtained. The 5’ portion of the ifk cDNA was obtained by 
RT-PCR using ifk-specific oligonucleotides. The PCR fragment was 
of the mur&ii cDNA(Siliciano et al., 1992; Heyeck and Berg, 1993). 
The full-length murine itk cDNA was then obtained by ligation of the 
5’ portion with the 3’ portion. The full-length if/r cDNA was subcloned 
into pcDNAI/Amp (Invitrogen) via BamHl and Xhol to generate pCA.ifk. 
Transient transfection of pCAit& and control plasmids into COS7 cells 
was achieved using calcium phosphate-precipitated DNA in a stan- 
dard protocol. 
Immunopreclpltatlon and Western Blot Analysis 
Generation of ES Cells Carrying the Designed Ifk Mutatlon COS cells or thymocytes in a single cell suspension in phosphate- 
Jl ES cells (a gift of Drs. E. Li and R. Jaenisch) were maintained, buffered saline (PBS) were lysed with the addition of an equal volume 
transfected, and selected as described (Li et al., 1992; Crooks and of 2x RIPA buffer (1 x RIPA: 150 mM NaCI, 50 mM Tris-HCI [pH 
Littman, 1994). Selection was maintained for 10 days, after which 7.51. 10 mM NaF, 1% sodium deoxycholate, 1% NP-40, and 0.1% 
individual colonies were picked with a 20 ul micropipet. Each colony SDS) containing protease and phosphotase inhibitors (final concentra- 
was incubated in a V-shaped well of microtiter plates for 10 min at tion: leupeptin, 10 jtg/ml; pepstatin, 2 @ml; SBTI, 10 f&g/ml; PMSF, 
37OC in 20 uI25 mM HEPES-buffered (pH 7.3) Hank’s Balanced Salt 2 mM; aprotinin, 50 &ml; sodium vanadate, 2.5 mM; and sodium 
Solution (without Caa or Mg-) containing 0.25% trypsin and 1 mM pyrophosphate, 6 mM) and incubating at 4OC for 20 min. The nuclei 
EDTA. Compl\te medium (200 ul) was added to each V-shaped well and cell debris were pelleted after spinning in a microfuge for 5 min. 
to terminate the trypsin digestion. 01 the dispersed ES cells, 160- Supernatants were collected and protein concentrations measured by 
200 sl were transferred to each well of 24-well plates without G416 the Bradley method (Bio-Rad). Total cell lysates (200 ug) were loaded 
selection. of the remaining dispersed ES cells from the V-shaped on a 7.5% SDS-PAGE gel. Alternatively, the thymocyte lysates (406 
wells, 5 pl were used for PCR analysis, initially in a pool with 5 other ug) were incubated for 1 hr at 4OC with ItkN4 (I:50 final), a polyclonal 
ES clones. After identifying a PCR-positive pool for homologous re- rabbit serum raised against a GST-fusion protein containing the 
combination at the ifk locus, each clone in the pool was analyzed by N-terminal region (amino acids l-175) of the mouse Itk protein. The 
PCR by taking 5 ftl again from the original cell suspension in the immune complex was precipitated by addition of 50 ul of 50% protein 
V-shaped wells. Only clones that gave a positive PCR signal for homol- A slurry in the lysis buffer. The immunoprecipitates were washed five 
ogous recombination were maintained in the 24-well plates by daily times with the lysis buffer and then boiled in 50 ul 2 x SDS sample 
change of medium. After 3 days, cells were harvested and frozen, loading dye containing 200 mM DTT before loading onto a 7.5% SDS- 
Southern Blot Analysis 
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PAGE gel. The gel was transferred to Immobilon-P membrane (Milli- 
pore) and incubated with ItkN4 (1:5000 in TBST with 5% nonfat dry 
milk) at room temperature for 1.5 hr. The secondary antibody (goat 
anti-rabbit-horseradish peroxidase. Boehringer Mannheim) was used 
at 1:20,000 followed by enhanced chemiluminescence detection of 
signals (Amersham). A different antiserum, ltkCL45, raised against a 
GST-fusion protein containing the C-terminal portion (amino acids 
175-819) of the mouse Itk protein, gave similar results for Itk immu- 
noblotting and immunoprecipitation (data not shown). 
Flow Cytometric Analysis 
Flow cytometry was performed by staining 10 freshly isolated thymo- 
cytes and lymph node cells in 198 ul of PBS supplemented with 0.3% 
bovine serum albumin and 0.01% sodium azide on ice for 30 min. For 
three-color analysis, cells were first stained with various biotin- 
conjugated antibodies against different lymphocyte surface proteins, 
followed by staining with a cocktail of streptavidin-TRICOLOR (Cal- 
tag), CD4-phycoerythrin (PE) (YTS191 .l, Caltag) and CDEfluores- 
cein isothiocyanate (FITC) (CT-CDBa, Caltag). Alternatively, lymph 
node cells were stained with CDS-PE (162C11, Pharmingen) and 
B220-FITC (RA3-862, Caltag). Cells were analyzed on a FACScan 
(Becton Dickinson) using the Lysis II software. Viable cells were gated 
on the basis of forward- and side-light scattering. Additional antibodies 
used were the following: anti-CD89 (H1.2F3), anti-heat stable antigen 
(M1/89), anti-TCRa8 (H57-597) anti-V83 (KJ25), anti-V88 (MR5-2) 
anti-Vall (RR8-1) and anti-IgM (R8-80.2) all from Pharmingen. Anti-H- 
Y-specific TCR (T3.70-biotin) was a gift of Dr. H.-S. Teh (University 
of British Columbia, Vancouver, Canada). 
Cell Prollferatlon Assays 
The complete medium (RPM1 1840 supplemented with 10% fetal calf 
eerum, 2 mM L-glutamine, 50 uM j3-mercaptoethanol, 100 pM nones- 
sential amino acids, 50 U/ml penicillin and 50 &ml streptomycin) was 
used for cell preparation and culture. Responder cells were isolated 
from lymph nodes of littermates of if/r+‘- and iti’- mice (8-10 weeks 
old, H-Pm). CD4+ cells were purified by means of depleting other cell 
populations. In brief, a 10 cm tissue culture dish was coated overnight 
at 4OC with 5 ml of 5 &ml rabbit anti-mouse immunoglobulin in PBS 
(Zymed). Prior to use, the dish was washed five times with PBS, fol- 
lowed by blocking with 5 ml complete medium at room temperature 
for 10 min. B cells from about 2 x 10’ lymph node cells (in 5 ml) were 
depleted by two rounds of panning procedures, each consisting of a 
30 min incubation at room temperature. To deplete CD8’ T cells and 
remaining B cells, nonadherent cells after panning were collected and 
resuspended in 0.3 ml complete medium ~1~~0.3 ml each of the hybrid- 
oma supernatant of Ml189 (rat anti-mouse HSA) and 538.72 (rat anti- 
mouse CD8a) for 30 min on ice. The cells were washed once and 
incubated with 200 ul of sheep anti-rat IgG-coated magnetic beads 
(Dynal) for 30 min on ice. The mixture was diluted and beads collected 
with a magnet. Cells remaining in suspension were harvested and 
found to contain typically 90% pure CD4+ T cells, which have not been 
inadvertently activated during preparation. 
Splenocytes from BALBlc (H-2dM) and C57BU8 (H-2m) were inacti- 
vated by irradiation (about 2000 rads). Proliferation assays were set 
up in a volume of 200 ul in flat-bottomed wells of microtiter plates. 
For the MLR, serial dilution of 4 x 105, 2 x 105, 1 x 105, and 0.5 x 
105 CD4+ cells were mixed with 5 x lo6 responder cells of various 
type in a well and incubated for 98 hr before pulsing for 24 hr with 1 
uCi of PH]thymidine per well. For other cell proliferation assays, 5 x 
l(rCD4’cellsweremixed with5 x 105irradiatedC57BU8splenocytes 
plus anti-CD3 (purified 145-2C11, at 1.5,0.5, 0.187, and 0.058 &t/ml 
final concentration), or ConA (at 1, 0.5. 0.25, and 0.125 uglml final 
concentration), or 0.125 @ml ConA plus various concentration of 
human recombinant IL-2 (R and D). PMA (1 @ml) and ionomycin 
(500 nglml) were added to 5 x 10’ CD4+ cells either with or without 
irradiated C57BU8 splenocytes. Cells were incubated for 48 hr before 
pulsing for24 hrwith 1 pCiof[SH]thymidineperwell. Cellular radioactiv- 
ity was harvested using a microtiter plate cell harvester (Tomtec). All 
assays were done in triplicates and the mean and standard deviation 
are presented. 
Acknowlsdgments 
We thank E. Li and R. Jaenisch for providing the Jl ES cell line and 
for advice on its manipulation; P. Soriano and H.-S. Teh for providing 
the 129/Sv genomic librav and the biotinconjugated T3.70 antibody, 
respectively; N. Cacalano for providing GST-ltk fusion constructs; C. 
Lai and G. Lemke for the degenerate PTK oligonucleotides and S. 
Stuart and Jun Wu for the cloning of murine if/r cDNA; C. Davis for 
advice on flow cytometry; N. Killeen and C. Crooks for advice on ES 
cell culture and blastocyst injection; M. Hill for advice on Western blot 
and immunoprecipitation as well as for sharing hybridoma superna- 
tan& C. Crooks, K. Boyd, and J. Scarborough for help with mouse 
breeding and screening; L. Luo for help with the figures; A. Weiss, N. 
Killeen, C. Crooks, C. Davis, M. Hill, and N. van Ders for valuable 
discussions and critical comments. We would like to thank N. Killeen 
for providing space to allow completion of this work. X. C. L. is sup- 
ported by the Cancer Research Fund of the Damon Runyon-Walter 
Winchell Foundation. D. R. L. is an investigator of the Howard Hughes 
Medical Institute. 
Received July 21, 1995; revised September 22, 1995. 
Aoki. Y., Isselbacher, K.J., and Pillai, S. (1994). Bruton tyrosine kinase 
is tyrosine phosphorylated and activated in pre-B lymphocytes and 
receptor-ligated B cells. Proc. Natl. Acad. Sci. USA 91, 10808-10809. 
Appleby, M.W.. Gross, J.A., Cooke, M.P., Levin, SD., Qian, X., and 
Perlmutter, R.M. (1992). Defective T cell receptor signaling in mice 
lacking the thymic isoform of p59h”. Cell 70, 751-783. 
Arpaia, E., Shahar, M., Dadi, H., Cohen, A., and Roifman, C.M. (1994). 
Defective T cell receptor signaling and CD8+ thymic selection in hu- 
mans lacking Zap-70 kinase. Cell 76, 947-958. 
August, A., Gibson, S., Kawakami, Y., Kawakami, T., Mills, G.B., and 
Dupont. B. (1994). CD28 is associated with and induces the immediate 
tyrosine phosphoryfation and activation of the Tee family kinase ITW 
EMT in the human Jurkat leukemic T-cell line. Proc. Natl. Acad. Sci. 
USA 97, 9347-9351. 
Chan, A.C., Kadlecek, T.A., Elder, M.E., Filipovich, A.H., Kuo, W.L., 
Iwashima, M.. Parslow, T.G., and Weiss, A. (1994). ZAP-70 deficiency 
in an autosomal recessive form of severe combined immunodefi- 
ciency. Science 264, 1599-l 801. 
Crooks, M.E.C., and Littman. D.R. (1994). Disruption of T lymphocyte 
positive and negative selection in mice lacking the CD8 8 chain, Immu- 
nity 1, 277-285. 
Davis, C.B., and Littman, D.R. (1995). Disrupted development of thy 
mocytes expressing a transgenic TCR upon CD4 overexpression. Int. 
Immunol., in press. 
de Weers, M., Brouns, G.S., Hinshelwood, S., Kinnon, C., Schuurman, 
R.K., Hendriks, R.W., and Borst, J. (1994). B-cell antigen receptor 
stimulation activates the human Bruton’s tyrosine kinase, which is 
deficient in X-linked agammaglobulinemia. J. Biol. Chem. 289,23857- 
23880. 
Desiderio, S.. and Siliciano, J.D. (1994). The Itk/Btk/Tecfamily of pro- 
tein-tyrosine kinases. Chem. Immunol. 59, 191-210. 
Elder, M.E., Lin, D., Clever, J., Chan, A.C., Hope, T.J., Weiss, A., and 
Parslow, T.G. (1994). Human severecombined immunodeficiencydue 
to a defect in ZAP-70, a T cell tyrosine kinase. Science 284, 1596 
1599. 
Gibson, S., Leung, B., Squire, J.A., Hill, M.,Arima, N., Goss, P., Hogg, 
D., and Mills, G.B. (1993). Identification, cloning, and characterization 
of a novel human T-cell-specific tyrosine kinase located at the hemato- 
poietin complex on chromosome 5q. Blood 82, 1581-1572. 
Hagemann, T.L., Chen, Y., Rosen, F.S., and Kwan, S.P. (1994). Geno- 
mic organization of the Btk gene and exon scanning for mutations 
in patients with X-linked agammaglobulinemia. Hum. Mol. Genet. 3, 
1743-l 749. 
Heyeck, S.D., and Berg, L.J. (1993). Developmental regulation of a 
immunity 
766 
murineT-cell-specifictyrosine kinasegene, Tsk. Proc. Natl. Acad. Sci. 
USA 90,669-673. 
Karnitz, L., Sutor, S.L., Torigoe, T., Reed, J.C., Bell, M.P., McKean, 
D.J.. Leibson, P.J., and Abraham, R.T. (1992). Effects of ~56~ defi- 
ciency on the growth and cytolytic effector function of an interleukin-2- 
dependent cytotoxic T-cell line. Mol. Cell. Biol. 12, 4521-4530. 
Kawakami, Y., Yao, L.. Miura, T., Tsukada, S., Witte, O.N., and Kawa- 
kami, T. (1994). Tyrosine phosphorylation and activation of Bruton 
tyrosine kinase upon FcsRI cross-linking. Mol. Cell. Biol. 14, 5106- 
5113. 
Kaye, J., Hsu, ML., Sauron, M.-E., Jameson, S.C., Gascoigne, N.R., 
and Hedrick, S.M. (1989). Selective development of CD4+ T cells in 
transgenic mice expressing a class II MHC-restricted antigen receptor. 
Nature 347, 746-749. 
Kaye, J., Vasquez, N.J., and Hedrick, S.M. (1992). Involvement of the 
same region of the T cell antigen receptor in thymic selection and 
foreign peptide recognition. J. Immunol. 148, 3342-3363. 
Khan, W.N., Alt, F.W., Gerstein, R.M., Malynn, B.A., Larsson, I., Rath- 
bun, G., Davidson, L., Muller, S., Kantor, A.B., Herzenberg, L.A., Ro- 
sen, F.S., and Sideras, P. (1995). Defective B cell development and 
function in BfIr-deficient mice. Immunity 3, 263-299. 
Lai, C., and Lemke, G. (1991). An extended family of protein-tyrosine 
kinase genes differentially expressed in the vertebrate nervous sys- 
tem. Neuron 6, 691-704. 
Laird, P.W., Zijdeweld, A., Linders, K., Rudnicki, M.A., Jaenisch, R., 
and Serns, A. (1991). Simplified mammalian DNA isolation procedure. 
Nucl. Acids Res. 19. 4293. 
Lee, N.A., Loh, D.Y., and Lacy, E. (1992). CD6 surface levels alter 
the fate of a/f3 T cell receptor-expressing thymocytes in transgenic 
mice. J. Exp. Med. 775, 1013-1025. 
Levin, SD., Anderson, S.J., Forbush. K.A.. and Perlmutter, R.M. 
(1993). A dominant-negative transgene defines a role for ~56~’ in thy- 
mopoiesis. EMBO J. 72, 1671-1660. 
Li, E., Bestor. T.H., and Jaenisch, R. (1992). Targeted mutation of the 
DNA methyltransferase gene results in embryonic lethality. Cell 69, 
915-926. 
Mano, H., Mano, K.,Tang, B., Koehler, M.,Yi,T.,Gilbert, D.J., Jenkins, 
N.A., Copeland, N.G., and Ihle, J.N. (1993). Expression of a novel 
form of Tee kinase in hematopoietic cells and mapping of the gene 
to chromosome 5 near Kit. Oncogene 8,417-424. 
Molina,T.J., Kishihara, K., Siderovski, D.P.,van Ewijk, W., Narendran, 
A., Timms, E., Wakeham, A., Paige, C.J., Hartmann, K.U., Veillette, 
A., Davidson, D., and Mak, T.W. (1992). Profound block in thymocyte 
development in mice lacking ~56~“. Nature 357, 161-164. 
Mombaerts, P., Anderson, S.J., Perlmutter, R.M., Mak, T.W., and To- 
negawa, S. (1994). An activated /c/r transgene promotes thymocyte 
development in RAG-1 mutant mice. Immunity 7, 261-267. 
Mond, J.J., Schaefer, M.. Smith, J., and Finkelman, F.D.(1963). Lyb-5 
B cells of CBA/N mice can be induced to synthesize DNA by culture 
with insolubilized but not soluble anti-lg. J. Immunol. 731,2107-2109. 
Musacchio, A., Gibson, T., Rice, P., Thompson, J., and Saraste, M. 
(1993). The PH domain: a common piece in the structural patchwork 
of signalling proteins. TIBS 18, 343-346. 
Negishi, I., Motoyama, N.. Nakayama, K.-i., Nakayama, K., Senju, 
A., Hatakeyama, S., Zhang, Q., Chan. A.C., and Loh, D.Y. (1995). 
Essential role for ZAP-70 in both positive and negative selection of 
thymocytes. Nature 376, 435-438. 
Ohta, Y., Haire, R.N., Litman, R.T.. Fu, SM., Nelson, R.P., Kratz, J., 
Kornfeld, S.J., de IaMorena, M., Good, R.A., and Litman. G.W. (1994). 
Genomic organization and structure of Bruton agammaglobulinemia 
tyrosine kinase: localization of mutations associated with varied clini- 
cal presentations and course in X chromosome-linked agammaglobu- 
linemia. Proc. Natl. Acad. Sci. USA 91, 9062-9066. 
Pearl, E.R.. Vogler, L.B., Okos, A.J., Crist, W.M., Lawton, A.R., and 
Cooper, M.D. (1976). 6 lymphocyte precursors in human bone marrow: 
an analysis of normal individuals and patients with antibody-deficiency 
states. J. Immunol. 720, 1169-l 175. 
Rawlings, D.J., Saffran, DC., Tsukada, S., Largaespada, D.A., Gri- 
maldi, J.C.,Cohen, L., Mohr, R.N., Baxan, J.F., Howard, M.,Copetand, 
N.G., Jenkins, N.A., and Witte, O.N. (lQQ3). Mutation of unique region 
of Bruton’s tyrosine kinase in immunodeficiency XID mice. Science 
267, 356-361. 
Robey, E.A., Ramsdell, F., Gordon, J.W., Mamalaki, C.. Kioussis, D., 
Youn, H.J., Gottlieb, P.D., Axel, R., and Fowlkes, B.J. (IQQ2a). Aself- 
reactive T cell population that is not subject to negative selection. Int. 
Immunol. 4, 969-974. 
Robey, E.A., Ramsdell. F., Kioussis, D., Sha, W., Loh, D.. Axel. R., 
and Fowlkes. B.J. (IQQ2b). The level of CD6 expression can determine 
the outcome of thymic selection. Cell 69, 106Q-1096. 
Rohrer. J., Parolino, O., Belmont, J.W.. and Conley, M.E. (1994). The 
genomic structure of human BTK, the defective gene in X-linked agam- 
maglobulinemia. Immunogenetics 40, 319324. 
Rothenberg, E.V. (lQQ4). Signaling mechanisms in thymocyte selec- 
tion. Curr. Cpin. Immunol. 6, 257-265. 
Russell, J.H., Meleedy-Rey, P., McCulley, D.E., Sha, W.C., Nelson, 
C.A., and Loh, D.Y. (1969). Evidence for CDEindependentTcell matu- 
ration in transgenic mice. J. Immunol. 144. 3316-3325. 
Saouaf. S.J., Mahajan, S.. Rowley, R.B., Kut, S.A., Fargnoli, J., Burk- 
hardt. A.L.,Tsukada, S., Witte, O.N., and Bolen, J.B. (1994)Temporal 
differences in the activation of three classes of non-transmembrane 
protein tyrosine kinases following B-cell antigen receptor surface en- 
gagement. Proc. Natl. Acad. Sci. USA 91, 9524-9526. 
Schonrich, G., Kalinke, Lt., Momburg, F., Malissen, M., Schmitt- 
Verhulst, A.M., Malissen, B., Hammerling, G.J.. and Arnold, 8. (1991). 
Down-regulation of T cell receptors on self-reactive T cells as a novel 
mechanism for extrathymic tolerance induction. Cell 85, 293-304. 
Shahinian, A., Lee, K.P., Kiindig, T.M., Kishihara, K., Wakeham, A., 
Kawai, K..Ohashi, P.S.,Thompson, C.B.,andMak,T.W.(1993). Differ- 
ential T cell costimulatory requirements in CD26deficient mice. Sci- 
ence 261, 609-612. 
Shaw, G. (1993). Identification of novel pleckstrin homology (PH) dc- 
mains provides a hypothesis for PH domain function. Biochem. Bio- 
phys. Res. Comm. 795, 1145-1151. 
Sideras, P., Muller, S., Shiels, H., Jin, H., Khan, W.N.. Nilsson. L., 
Parkinson, E., Thomas, J.D., Branden, L., Larsson. I., Paul, W.E., 
Rosen, F.S., Alt, F.W., Vetrie, D., Smith, C.I.E., and Xanthopoulos, 
K.G. (1994). Genomic organization of mouse and human Bruton’s 
agammaglobulinemia tyrosine kinase (Btk) loci. J. Immunol. 153. 
5607-5617. 
Siliciano, J.D., Morrow, T.A.. and Desiderio, S.V. (1992). it/r, a Ttell- 
specific tyrosine kinase gene inducible by interleukin 2. Proc. Natl. 
Acad. Sci. USA 89, 11194-l 1196. 
Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991). Tar- 
geted disruption of the c-src proto-oncogene leads to osteopetrosis 
in mice. Cell 64, 693-702. 
Stein, P.L., Lee, H.-M., Rich, S., and Soriano, P. (1992). pp59h” mutant 
mice display differential signaling in thymocytes and peripheral Tcells. 
Cell 70. 741-750. 
Straus, D.B., and Weiss, A. (1992). Genetic evidence for the involve- 
ment of the Ick tyrosine kinase in signal transduction through the T 
cell antigen receptor. Cell 70, 565-593. 
Tanaka, N., Asao, H., Ohtani, K., Nakamura, M., and Sugamura, K. 
(1993). A novel human tyrosine kinase gene inducible in T cells by 
interleukin 2. FEBS Lett. 324, l-5. 
Teh, H.S., Kisielow. P., Scott, B., Kishi, H., Uematsu. Y., Bluthmann, 
H., and von Boehmer. H. (1988). Thymic major histocompatibilitycom- 
plex antigens and the a5 T-cell receptor determine the CD4/CD6 phe- 
notype of T cells. Nature 335, 229-233. 
Teh, H.S., Kishi. H., Scott, B., and Von Boehmer, H. (1989). Deletion 
of autospecific T cells in T cell receptor (TCR) transgenic mice spares 
cells with normal TCR levels and low levels of CD6 molecules. J. Exp. 
Med. 169, 795-606. 
Thomas, J.D., Sideras, P., Smith, C.I.E., Vorechovsky, I., Chapman, 
V., and Paul, W.E. (1993). Colocalization of X-linked agammaglobu- 
T Cell Phenotype in Itk-Deficient Mice 
769 
IinemiaandX-linked immunodeficiencygenes. Science261,355-356. 
Tsukada, S., Saffran, DC., Rawlings, D.J., Parolini. O., Allen, R.C., 
Klisak, I., Sparkes, R.S.. Kubagawa, H., Mohandas, T., Quart, S., Bel- 
mont, J.W., Cooper, M.D., Conley, ME., and Witte, O.N. (1993). Defi- 
cient expression of a B cell cytoplasmic tyrosine kinase in human 
X-linked agammaglobulinemia. Cell 72. 279-290. 
Tsukada, S., Rawlings, D.J., and Witte, O.N. (1994). Role of Bruton’s 
tyrosine kinase in immunodeficiency. Curr. Opin. Immunol. 6. 623- 
630. 
Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and 
Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with 
a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153- 
1163. 
Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, 
F., Hammarstri)m, L., Kinnon, C., Levinsky, R., Bobrow, M.. Smith, 
C.I.E., and Bentley, D.R. (1993). The gene involved in X-linked agam- 
maglobulinaemia is a member of the src family of protein-tyrosine 
kinases. Nature 361, 226-233. 
von Boehmer, H. (1996). Developmental biology of T cells in T cell- 
receptor transgenic mice. Annu. Rev. Immunol. 8, 531-556. 
Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte 
antigen receptors. Cell 76, 263-274. 
Yamada, N., Kawakami, Y., Kimura, H.. Fukamachi, H., Baier, G., 
Altman, A., Kato, T., Yoshimasa, I., and Kawakami, T. (1993). Structure 
and expression of novel protein-tyrosine kinases, emb and emt, in 
hematopoietic cells. Biochem. Biophy. Res. Comm. 192, 231-240. 
Yenofsky, R.L., Fine, M., and Pellow, J.W. (1990). A mutant neomycin 
phosphotransferase II gene reduces the resistance of transformants 
to antibiotic selection pressure. Proc. Natl. Acad. Sci. USA 87, 343C 
3439. 
